---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-26-002304"
form_type: "8-K"
ticker: "ZOMDF"
cik: "0001684144"
company_name: "Zomedica Corp."
filed_at: "2026-03-16T23:59:59+00:00"
generated_at: "2026-05-15T11:49:05.916631+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Zomedica reports record Q4 revenue $10.5M, full-year revenue $32.0M (+17% YoY)

## Summary
- Q4 revenue $10.5M (+33% YoY); full year $32.0M (+17%). Record 20th straight YoY increase.
- Gross margin 68% for year; Q4 69% best quarter. Adjusted EBITDA loss improved to $17.1M from $20.2M.
- Cash burn reduced to $18.1M for year, $1.1M in Q4; cash/securities $53.3M.
- Consumable revenue grew 16% to $20.7M; Development Services segment contributed $3.1M.
- Net loss $81.9M includes $55.8M non-cash impairment; operating expenses ex-impairment down 7%.

## SEC filing metadata
- accession: 0001654954-26-002304
- form_type: 8-K
- ticker: ZOMDF
- cik: 0001684144
- company_name: Zomedica Corp.
- filed_at: 2026-03-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1684144/000165495426002304/0001654954-26-002304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1684144/000165495426002304/zom_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-26-002304
- JSON: https://secwatch.observer/filing/0001654954-26-002304.json
- Plain text: https://secwatch.observer/filing/0001654954-26-002304.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.